Does SECUKINUMAB Cause Hypercholesterolaemia? 1,148 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,148 reports of Hypercholesterolaemia have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.8% of all adverse event reports for SECUKINUMAB.
1,148
Reports of Hypercholesterolaemia with SECUKINUMAB
0.8%
of all SECUKINUMAB reports
1,097
Deaths
900
Hospitalizations
How Dangerous Is Hypercholesterolaemia From SECUKINUMAB?
Of the 1,148 reports, 1,097 (95.6%) resulted in death, 900 (78.4%) required hospitalization, and 956 (83.3%) were considered life-threatening.
Is Hypercholesterolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 1,148 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Hypercholesterolaemia?
ALENDRONATE (1,607)
METHOTREXATE (1,547)
TOCILIZUMAB (1,483)
ADALIMUMAB (1,479)
ABATACEPT (1,410)
RITUXIMAB (1,389)
PREDNISONE (1,377)
INFLIXIMAB (1,338)
DICLOFENAC (1,331)
LEFLUNOMIDE (1,322)
Which SECUKINUMAB Alternatives Have Lower Hypercholesterolaemia Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG